florquinitau f-18 · Cerveau Lantheus · NDA 220496
Tauklarify
Earliest generic entry, as listed
9 Jun 2035
Blocked by patent: US 10022461, US 9808542.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10022461 | use U-4597 · sets the listed date | 9 Jun 2035 |
| US 9808542 | drug substance, drug product, use U-4597 · sets the listed date | 9 Jun 2035 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 13 Aug 2031 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 220496 · 001 · RLD | solution, intravenous | 1-40mCi/ML | 9 Jun 2035 |